128 related articles for article (PubMed ID: 38498796)
21. Analysis of Epstein-Barr Virus (EBV) and PD-L1 Expression in Nasopharyngeal Carcinoma Patients in a Non-Endemic Region.
Dias JM; Santana IVV; da Silva VD; Carvalho AL; Arantes LMRB
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233023
[TBL] [Abstract][Full Text] [Related]
22. Programmed Death-Ligand 1 Expression, Microsatellite Instability, Epstein-Barr Virus, and Human Papillomavirus in Nasopharyngeal Carcinomas of Patients from the Philippines.
Chang AMV; Chiosea SI; Altman A; Pagdanganan HA; Ma C
Head Neck Pathol; 2017 Jun; 11(2):203-211. PubMed ID: 27807760
[TBL] [Abstract][Full Text] [Related]
23. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
[TBL] [Abstract][Full Text] [Related]
24. Nuclear factor-Y and Epstein Barr virus in nasopharyngeal cancer.
Chia MC; Leung A; Krushel T; Alajez NM; Lo KW; Busson P; Klamut HJ; Bastianutto C; Liu FF
Clin Cancer Res; 2008 Feb; 14(4):984-94. PubMed ID: 18281530
[TBL] [Abstract][Full Text] [Related]
25. A11 Tetramer-assisted characterization of Rta-specific CD8+ T-cell responses in healthy virus carriers.
Yu HX; Srinivasan N; Ren EE; Chan SH
Tissue Antigens; 2005 Jun; 65(6):539-43. PubMed ID: 15896201
[TBL] [Abstract][Full Text] [Related]
26. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
Wille CK; Nawandar DM; Henning AN; Ma S; Oetting KM; Lee D; Lambert P; Johannsen EC; Kenney SC
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7257-65. PubMed ID: 26663912
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
[TBL] [Abstract][Full Text] [Related]
28. The Dietary Flavonol Kaempferol Inhibits Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma Cells.
Wu CC; Lee TY; Cheng YJ; Cho DY; Chen JY
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500249
[TBL] [Abstract][Full Text] [Related]
29. Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma.
Liao Y; Zhang JB; Lu LX; Jia YJ; Zheng MQ; Debelius JW; He YQ; Wang TM; Deng CM; Tong XT; Xue WQ; Cao LJ; Wu ZY; Yang DW; Zheng XH; Li XZ; Wu YX; Feng L; Ye W; Mu J; Jia WH
Microbiol Spectr; 2023 Feb; 11(1):e0344822. PubMed ID: 36645283
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr Virus-Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1.
Ge J; Wang J; Xiong F; Jiang X; Zhu K; Wang Y; Mo Y; Gong Z; Zhang S; He Y; Li X; Shi L; Guo C; Wang F; Zhou M; Xiang B; Li Y; Li G; Xiong W; Zeng Z
Cancer Res; 2021 Oct; 81(19):5074-5088. PubMed ID: 34321242
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Value of Programmed Cell Death-Ligand 1 Expression in Tumor-Infiltrating Lymphocytes and Viral Load in Peripheral Blood Mononuclear Cells for Epstein-Barr Virus-Positive Nasopharyngeal Carcinoma.
Hu B; Sun M; Wang Z; Zheng Y; Cai W; Shi HH; Zhuang Y; Lin Q
Clin Chem; 2020 Sep; 66(9):1219-1227. PubMed ID: 32870999
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.
Jung YJ; Choi H; Kim H; Lee SK
J Virol; 2014 Aug; 88(16):9027-37. PubMed ID: 24899173
[TBL] [Abstract][Full Text] [Related]
33. Comprehensive profiling of EBV gene expression in nasopharyngeal carcinoma through paired-end transcriptome sequencing.
Hu L; Lin Z; Wu Y; Dong J; Zhao B; Cheng Y; Huang P; Xu L; Xia T; Xiong D; Wang H; Li M; Guo L; Kieff E; Zeng Y; Zhong Q; Zeng M
Front Med; 2016 Mar; 10(1):61-75. PubMed ID: 26969667
[TBL] [Abstract][Full Text] [Related]
34. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW
J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
[TBL] [Abstract][Full Text] [Related]
35. Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities.
Lenoci D; Resteghini C; Serafini MS; Pistore F; Canevari S; Ma B; Cavalieri S; Alfieri S; Trama A; Licitra L; De Cecco L
Transl Res; 2024 Mar; 265():1-16. PubMed ID: 37949350
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
Guo J; Cui Z; Zheng Y; Li X; Chen Y
Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
[TBL] [Abstract][Full Text] [Related]
37. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
38. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
39. N-methyl-N'-nitro-N-nitrosoguanidine induces and cooperates with 12-O-tetradecanoylphorbol-1,3-acetate/sodium butyrate to enhance Epstein-Barr virus reactivation and genome instability in nasopharyngeal carcinoma cells.
Huang SY; Fang CY; Tsai CH; Chang Y; Takada K; Hsu TY; Chen JY
Chem Biol Interact; 2010 Dec; 188(3):623-34. PubMed ID: 20869957
[TBL] [Abstract][Full Text] [Related]
40. Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis.
Feng P; Chan SH; Soo MY; Liu D; Guan M; Ren EC; Hu H
Cancer; 2001 Oct; 92(7):1872-80. PubMed ID: 11745260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
